IMGN901: Phase I/II data

Pooled data from 68 evaluable small cell lung cancer (SCLC) patients in the Phase I Study 002 trial and the Phase I/II Study 001 trial showed that IMGN901 produced 1 PR, 1 unconfirmed PR and 15 cases ...